Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

MDGLMADRIGAL PHARMACEUTICALS, INC.

Nasdaq · CIK 0001157601
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts311

Identity from submissions API

NameMADRIGAL PHARMACEUTICALS, INC.
CIK0001157601
TickersMDGL
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(267) 824-2827
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • MADRIGAL PHARMACEUTICALS, INC. (2016-08-11T04:00:00.000Z → 2026-11-16T05:00:00.000Z)
  • SYNTA PHARMACEUTICALS CORP (2002-05-31T04:00:00.000Z → 2016-08-01T04:00:00.000Z)
Business address
1001 CONSHOHOCKEN STATE ROAD
SUITE 2-350
WEST CONSHOHOCKEN
PA
PA
Mailing address
1001 CONSHOHOCKEN STATE ROAD
SUITE 2-350
WEST CONSHOHOCKEN
PA
PA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1225 filing rows loaded from submissions recent; extra archives: CIK0001157601-submissions-001.json (225 filings, 2002-05-31 to 2011-01-12).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001231919-26-001577 005-82674 261555639 34 10626
2026-11-06 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-124003 005-82674 261533292 34 48687
2026-11-06 4 4 0001193125-26-452132 28157
2026-11-06 4 FORM 4 0001628280-26-071744 5066
2026-11-06 144 xsl144X01/primary_doc.xml 0001950047-26-010779 001-33277 261532379 33 5801
2026-11-03 10-Q 10-Q 0001628280-26-069145 001-33277 261514610 34 7103255 1 1
2026-11-03 8-K 8-K 2.02,9.01 0001628280-26-069093 001-33277 261514285 34 611957 1 1
2026-09-28 144 xsl144X01/primary_doc.xml 0001950047-26-009840 001-33277 261417488 33 5115
2026-09-11 4 FORM 4 0001628280-26-061581 43825
2026-09-11 144 xsl144X01/primary_doc.xml 0001950047-26-009360 001-33277 261374760 33 6760
2026-09-09 144 xsl144X01/primary_doc.xml 0001628280-26-061190 001-33277 261369168 33 6018
2026-08-20 4 FORM 4 0001628280-26-058256 5207
2026-08-20 144 xsl144X01/primary_doc.xml 0001628280-26-058254 001-33277 261300107 33 5171
2026-08-18 4 FORM 4 0001628280-26-057751 7487
2026-08-18 3 FORM 3 0001628280-26-057747 407141
2026-08-12 8-K 8-K 5.02,7.01,9.01 0001628280-26-055962 001-33277 261265411 34 182465 1 1
2026-07-30 10-Q 10-Q 0001628280-26-050845 001-33277 261220444 34 10197357 1 1
2026-07-30 8-K 8-K 2.02,9.01 0001628280-26-050775 001-33277 261220129 34 433420 1 1
2026-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002902 005-82674 261216962 34 11352
2026-07-20 4 FORM 4 0001628280-26-048919 25208
2026-07-20 144 xsl144X01/primary_doc.xml 0001628280-26-048913 001-33277 261187981 33 5219
2026-06-18 4 FORM 4 0001628280-26-044346 8521
2026-06-18 4 FORM 4 0001628280-26-044340 7363
2026-06-18 4 FORM 4 0001628280-26-044325 7381
2026-06-18 4 FORM 4 0001628280-26-044307 7403
2026-06-18 4 FORM 4 0001628280-26-044290 7400
2026-06-18 4 4 0001193125-26-275800 27524
2026-06-17 S-8 FORM S-8 0001104659-26-075183 333-296861 261099056 33 574517 1 1
2026-06-17 8-K FORM 8-K 5.02,5.07,9.01 0001104659-26-075130 001-33277 261098370 34 549317 1 1
2026-06-01 4 FORM 4 0001628280-26-039653 5010
2026-06-01 144 xsl144X01/primary_doc.xml 0001950047-26-005407 001-33277 261051508 33 5726
2026-05-22 4 FORM 4 0001628280-26-037830 23324
2026-05-22 144 xsl144X01/primary_doc.xml 0001950047-26-004992 001-33277 261014528 33 5098
2026-05-18 4 FORM 4 0001628280-26-036078 5161
2026-05-18 144 xsl144X01/primary_doc.xml 0001628280-26-036075 001-33277 26995129 33 5084
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001013594-26-000612 005-82674 26989030 34 8328
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000142 005-82674 26984910 34 12269
2026-05-06 10-Q 10-Q 0001628280-26-030947 001-33277 26946159 34 8245493 1 1
2026-05-06 8-K 8-K 2.02,9.01 0001628280-26-030896 001-33277 26945782 34 415389 1 1
2026-04-28 8-K 8-K 5.02 0001628280-26-027956 001-33277 26908214 34 143445 1 1
2026-04-28 ARS ARS 0001104659-26-050364 001-33277 26908062 34 877019
2026-04-28 DEFA14A DEFA14A 0001104659-26-050349 001-33277 26907920 34 297406
2026-04-28 DEF 14A DEFINITIVE PROXY STATEMENT 0001308179-26-000352 001-33277 26907592 34 28049679 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001789 005-82674 26802160 34 7329
2026-03-06 4 FORM 4 0001628280-26-015775 26808
2026-03-06 144 xsl144X01/primary_doc.xml 0001628280-26-015771 001-33277 26732737 33 6134
2026-03-06 4 FORM 4 0001628280-26-015769 9091
2026-03-06 144 xsl144X01/primary_doc.xml 0001628280-26-015767 001-33277 26732702 33 5539
2026-03-06 4 FORM 4 0001628280-26-015763 9063
2026-03-06 144 xsl144X01/primary_doc.xml 0001628280-26-015760 001-33277 26732659 33 6183
2026-03-06 4 FORM 4 0001628280-26-015758 9077
2026-03-06 144 xsl144X01/primary_doc.xml 0001628280-26-015740 001-33277 26732603 33 6193
2026-03-06 4 FORM 4 0001628280-26-015736 6098
2026-03-06 144 xsl144X01/primary_doc.xml 0001628280-26-015734 001-33277 26732584 33 8893
2026-03-06 4 FORM 4 0001628280-26-015722 7337
2026-03-06 144 xsl144X01/primary_doc.xml 0001950047-26-002326 001-33277 26731521 33 5866
2026-03-02 4 FORM 4 0001628280-26-013394 4979
2026-03-02 144 xsl144X01/primary_doc.xml 0001628280-26-013391 001-33277 26709632 33 5466
2026-02-24 4 FORM 4 0001628280-26-011211 6711
2026-02-19 10-K 10-K 0001628280-26-009514 001-33277 26651683 34 38701191 1 1
2026-02-19 8-K 8-K 2.02,9.01 0001628280-26-009476 001-33277 26651457 34 323066 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001013594-26-000264 005-82674 26643590 34 8595
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-26-000090 005-82674 26642404 34 12186
2026-01-30 8-K FORM 8-K 1.01,9.01 0001104659-26-008698 001-33277 26584267 34 227396 1 1
2026-01-26 4 FORM 4 0001628280-26-003491 6713
2026-01-26 4 FORM 4 0001628280-26-003482 6629
2026-01-26 144 xsl144X01/primary_doc.xml 0001628280-26-003478 001-33277 26561501 33 6876
2026-01-26 4 FORM 4 0001628280-26-003468 5070
2026-01-26 144 xsl144X01/primary_doc.xml 0001628280-26-003462 001-33277 26561327 33 5537
2026-01-26 4 FORM 4 0001628280-26-003452 6098
2026-01-26 144 xsl144X01/primary_doc.xml 0001628280-26-003442 001-33277 26561237 33 8210
2026-01-26 144 xsl144X01/primary_doc.xml 0001950047-26-000688 001-33277 26560886 33 6486
2026-01-20 4 FORM 4 0001628280-26-002742 6594
2026-01-20 144 xsl144X01/primary_doc.xml 0001628280-26-002739 001-33277 26544140 33 5501
2026-01-20 4 FORM 4 0001628280-26-002735 6099
2026-01-20 144 xsl144X01/primary_doc.xml 0001628280-26-002729 001-33277 26544087 33 7573
2026-01-20 4 FORM 4 0001628280-26-002687 7374
2026-01-20 3 FORM 3 0001628280-26-002680 404798
2026-01-20 144 xsl144X01/primary_doc.xml 0001950047-26-000588 001-33277 26543474 33 5057
2026-01-13 4 FORM 4 0001628280-26-001981 9992
2026-01-13 4 FORM 4 0001628280-26-001976 53998
2026-01-13 4 FORM 4 0001628280-26-001970 11361
2026-01-13 4 FORM 4 0001628280-26-001961 53226
2026-01-09 144 xsl144X01/primary_doc.xml 0001950047-26-000299 001-33277 26523407 33 6446
2025-12-12 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-120744 005-82674 251569385 34 14500
2025-12-12 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-120743 005-82674 251569380 34 14480
2025-12-12 4 FORM 4 0001628280-25-056794 22954
2025-12-12 4 FORM 4 0001628280-25-056792 24482
2025-12-11 8-K 8-K 5.02 0001628280-25-056533 001-33277 251565163 34 148997 1 1
2025-12-10 144 xsl144X01/primary_doc.xml 0001950047-25-010080 001-33277 251562226 33 5189
2025-12-10 144 xsl144X01/primary_doc.xml 0001950047-25-010079 001-33277 251562222 33 4856
2025-12-04 4 FORM 4 0001628280-25-055430 10005
2025-12-04 144 xsl144X01/primary_doc.xml 0001628280-25-055416 001-33277 251550511 33 5618
2025-12-03 4 FORM 4 0001628280-25-055164 32295
2025-12-02 144 xsl144X01/primary_doc.xml 0001950047-25-009623 001-33277 251543500 33 5104
2025-11-21 4 FORM 4 0001628280-25-053648 21730
2025-11-21 144 xsl144X01/primary_doc.xml 0001628280-25-053607 001-33277 251508347 33 6505
2025-11-14 4 FORM 4 0001628280-25-052411 33334
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000297 005-82674 251483250 34 9677
2025-11-13 144 xsl144X01/primary_doc.xml 0001950047-25-008831 001-33277 251478963 33 5080
2025-11-07 4 FORM 4 0001628280-25-050668 31456
2025-11-05 144 xsl144X01/primary_doc.xml 0001950047-25-008473 001-33277 251454207 33 5635
2025-11-04 10-Q 10-Q 0001628280-25-048559 001-33277 251446784 34 64922130 1 1
2025-11-04 8-K 8-K 2.02,9.01 0001628280-25-048525 001-33277 251446396 34 356755 1 1
2025-09-11 S-8 FORM S-8 0001410578-25-002071 333-290192 251308908 33 222293 1 1
2025-09-09 144 xsl144X01/primary_doc.xml 0001104659-25-088744 001-33277 251304503 33 5594
2025-09-09 4 FORM 4 0001518611-25-000009 5019
2025-08-29 144 xsl144X01/primary_doc.xml 0001950047-25-006533 001-33277 251280866 33 7116
2025-08-21 4 FORM 4 0001518611-25-000007 7136
2025-08-21 144 xsl144X01/primary_doc.xml 0001950047-25-006183 001-33277 251241171 33 5355
2025-08-20 4 4 0000950170-25-110502 68502
2025-08-20 4 4 0000950170-25-110498 71978
2025-08-20 144 xsl144X01/primary_doc.xml 0001950047-25-006084 001-33277 251236917 33 6358
2025-08-18 4 FORM 4 0002034056-25-000009 16728
2025-08-18 144 xsl144X01/primary_doc.xml 0002034056-25-000007 001-33277 251228964 33 6457
2025-08-18 144 xsl144X01/primary_doc.xml 0001950047-25-005976 001-33277 251228196 33 5601
2025-08-15 4 FORM 4 0001210238-25-000005 16665
2025-08-15 144 xsl144X01/primary_doc.xml 0001950047-25-005943 001-33277 251225769 33 4844
2025-08-15 144 xsl144X01/primary_doc.xml 0001950047-25-005932 001-33277 251225260 33 4873
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000223 005-82674 251215821 34 9677
2025-08-13 4 FORM 4 0001236927-25-000007 36356
2025-08-13 4 FORM 4 0001236927-25-000005 31508
2025-08-13 4 FORM 4 0001423898-25-000005 31472
2025-08-13 144 xsl144X01/primary_doc.xml 0001950047-25-005768 001-33277 251212014 33 13080
2025-08-12 144 xsl144X01/primary_doc.xml 0001950047-25-005679 001-33277 251207151 33 11450
2025-08-12 144 xsl144X01/primary_doc.xml 0001950047-25-005675 001-33277 251207140 33 11481
2025-08-11 144 xsl144X01/primary_doc.xml 0001950047-25-005633 001-33277 251202389 33 9330
2025-08-11 144 xsl144X01/primary_doc.xml 0001950047-25-005631 001-33277 251202380 33 9853
2025-08-05 4 FORM 4 0001628280-25-038008 7261
2025-08-05 3 FORM 3 0001628280-25-038006 404483
2025-08-05 10-Q 10-Q 0001628280-25-037613 001-33277 251183125 34 7020370 1 1
2025-08-05 8-K 8-K 2.02,9.01 0001628280-25-037596 001-33277 251182753 34 796427 1 1
2025-07-30 8-K FORM 8-K 7.01,9.01 0001104659-25-071928 001-33277 251163865 34 223745 1 1
2025-07-22 4 FORM 4 0001628280-25-035583 9963
2025-07-22 4 FORM 4 0001628280-25-035580 9997
2025-07-22 8-K 8-K 1.01,1.02,2.03,7.01,9.01 0001628280-25-035506 001-33277 251138750 34 203608 1 1
2025-07-18 144 xsl144X01/primary_doc.xml 0001950047-25-005109 001-33277 251135252 33 7902
2025-07-18 144 xsl144X01/primary_doc.xml 0001950047-25-005107 001-33277 251135105 33 7940
2025-07-18 4 FORM 4 0001628280-25-035342 26567
2025-07-18 4 FORM 4 0001628280-25-035340 26531
2025-07-17 144 xsl144X01/primary_doc.xml 0001950047-25-005087 001-33277 251130885 33 6507
2025-07-17 144 xsl144X01/primary_doc.xml 0001950047-25-005086 001-33277 251130881 33 6469
2025-07-16 144 xsl144X01/primary_doc.xml 0001950047-25-005063 001-33277 251127674 33 5110
2025-07-16 144 xsl144X01/primary_doc.xml 0001950047-25-005061 001-33277 251127663 33 5149
2025-06-24 4 FORM 4 0001628280-25-032863 7184
2025-06-24 4 FORM 4 0001628280-25-032861 7164
2025-06-24 4 FORM 4 0001628280-25-032855 7179
2025-06-24 4 4 0000950170-25-089481 26952
2025-06-24 4 FORM 4 0001628280-25-032850 7204
2025-06-24 4 FORM 4 0001628280-25-032846 8354
2025-06-20 S-8 FORM S-8 0001104659-25-061176 333-288200 251061674 33 532715 1 1
2025-06-20 8-K 8-K 5.07 0001628280-25-032358 001-33277 251061277 34 163942 1 1
2025-05-16 4 FORM 4 0001628280-25-026346 7334
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000140 005-82674 25943874 34 9677
2025-05-01 10-Q 10-Q 0001628280-25-021356 001-33277 25899749 34 5539550 1 1
2025-05-01 8-K 8-K 2.02,9.01 0001628280-25-021314 001-33277 25899346 34 1770476 1 1
2025-04-29 ARS ARS 0001104659-25-041286 001-33277 25888164 34 13587200
2025-04-29 DEFA14A DEFA14A 0001104659-25-041275 001-33277 25888017 34 309032
2025-04-29 DEF 14A DEF 14A 0001104659-25-041254 001-33277 25887847 34 6806118 1 1
2025-04-24 3 FORM 3 0001628280-25-019732 404852
2025-04-17 8-K 8-K 5.02 0001628280-25-018242 001-33277 25848020 34 153786 1 1
2025-04-11 4 FORM 4 0001628280-25-017563 6718
2025-03-14 4 FORM 4 0001628280-25-012826 37300
2025-03-13 144 xsl144X01/primary_doc.xml 0001950047-25-001840 001-33277 25736721 33 7116
2025-03-13 144/A xsl144X01/primary_doc.xml 0001963745-25-000001 001-33277 25734931 33 4603
2025-03-12 4 FORM 4 0001628280-25-012369 4833
2025-03-12 4 FORM 4 0001628280-25-012364 7249
2025-03-12 3 FORM 3 0001628280-25-012357 405637
2025-03-12 144 xsl144X01/primary_doc.xml 0001950047-25-001780 001-33277 25731846 33 5448
2025-03-11 8-K 8-K 5.02,7.01,9.01 0001193125-25-051461 001-33277 25725902 34 178559 1 1
2025-03-07 4 FORM 4 0001628280-25-011410 7393
2025-03-07 4 FORM 4 0001628280-25-011407 7299
2025-03-07 4 FORM 4 0001628280-25-011405 29945
2025-03-07 4 FORM 4 0001628280-25-011359 8487
2025-03-07 4 FORM 4 0001628280-25-011354 7367
2025-03-07 4 FORM 4 0001628280-25-011321 7381
2025-03-05 4 FORM 4 0001628280-25-010510 4896
2025-03-05 4 FORM 4 0001628280-25-010508 7063
2025-03-05 4 FORM 4 0001628280-25-010492 17387
2025-03-05 144 xsl144X01/primary_doc.xml 0001950047-25-001566 001-33277 25710952 33 6265
2025-03-04 4 FORM 4 0001628280-25-010224 6875
2025-03-03 144 xsl144X01/primary_doc.xml 0000950170-25-031242 001-33277 25700978 33 7647
2025-03-03 144 xsl144X01/primary_doc.xml 0001950047-25-001459 001-33277 25698904 33 5804
2025-03-03 144 xsl144X01/primary_doc.xml 0001950047-25-001372 001-33277 25698034 33 6402
2025-02-28 144 xsl144X01/primary_doc.xml 0001950047-25-001361 001-33277 25691833 33 4908
2025-02-28 4 FORM 4 0001628280-25-009091 7983
2025-02-28 4 FORM 4 0001628280-25-009079 15256
2025-02-28 4 FORM 4 0001628280-25-009076 28000
2025-02-27 144 xsl144X01/primary_doc.xml 0001950047-25-001329 001-33277 25680308 33 5505
2025-02-27 144 xsl144X01/primary_doc.xml 0001950047-25-001328 001-33277 25680258 33 6088
2025-02-26 10-K 10-K 0001628280-25-007980 001-33277 25666407 34 10506729 1 1
2025-02-26 8-K 8-K 2.02,9.01 0001193125-25-035787 001-33277 25666126 34 254467 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000066 005-82674 25625511 34 9692
2025-01-27 4 FORM 4 0001628280-25-002680 5091
2025-01-27 4 FORM 4 0001628280-25-002666 5099
2025-01-27 4 FORM 4 0001628280-25-002658 6193
2025-01-27 4 FORM 4 0001628280-25-002655 5079
2025-01-24 144 xsl144X01/primary_doc.xml 0000950170-25-008924 001-33277 25555371 33 5459
2025-01-24 144 xsl144X01/primary_doc.xml 0000950170-25-008923 001-33277 25555370 33 4815
2025-01-24 144 xsl144X01/primary_doc.xml 0000950170-25-008922 001-33277 25555369 33 5472
2025-01-24 144 xsl144X01/primary_doc.xml 0000950170-25-008921 001-33277 25555368 33 5480
2025-01-17 4 FORM 4 0001628280-25-001902 5076
2025-01-17 4 FORM 4 0001628280-25-001900 5079
2025-01-17 4 FORM 4 0001628280-25-001898 6194
2025-01-17 144 xsl144X01/primary_doc.xml 0000950170-25-006816 001-33277 25539709 33 4738
2025-01-17 144 xsl144X01/primary_doc.xml 0000950170-25-006815 001-33277 25539707 33 4745
2025-01-17 144 xsl144X01/primary_doc.xml 0000950170-25-006814 001-33277 25539706 33 4742
2025-01-13 8-K 8-K 2.02,9.01 0001193125-25-004939 001-33277 25524717 34 187267 1 1
2024-12-05 4 FORM 4 0001628280-24-050094 9787
2024-11-27 4 FORM 4 0001628280-24-049400 9788
2024-11-25 144 xsl144X01/primary_doc.xml 0002002698-24-000480 001-33277 241495977 33 4377
2024-11-22 4 4 0000950170-24-130239 16843
2024-11-21 144 xsl144X01/primary_doc.xml 0000950170-24-129738 001-33277 241484852 33 4442
2024-11-14 SC 13G/A madrigal13ga2-11142024.htm 0001013594-24-000984 005-82674 241464356 34 73318
2024-11-14 SC 13G/A JANUS AMENDMENT 0001274173-24-000122 005-82674 241461406 34 10644
2024-11-14 SC 13G p24-3253sc13g.htm 0000902664-24-006493 005-82674 241456971 34 68171
2024-11-08 4 4 0000950170-24-124232 8213
2024-11-07 144 xsl144X01/primary_doc.xml 0001950047-24-008242 001-33277 241436474 33 5784
2024-11-05 4 4 0000950170-24-121722 13713
2024-11-01 144 xsl144X01/primary_doc.xml 0001950047-24-008031 001-33277 241419715 33 5045
2024-10-31 S-8 S-8 0001193125-24-248732 333-282926 241415726 33 217745 1 1
2024-10-31 10-Q 10-Q 0001628280-24-044445 001-33277 241412677 34 25435021 1 1
2024-10-31 8-K 8-K 2.02,9.01 0001193125-24-248137 001-33277 241412394 34 233877 1 1
2024-09-17 4 4 0000950170-24-107561 7347
2024-09-11 4 4 0000950170-24-105650 5029
2024-09-10 144 xsl144X01/primary_doc.xml 0000950170-24-105327 001-33277 241291338 33 4531
2024-08-19 4 4 0000950170-24-098804 7314
2024-08-15 3 3 0000950170-24-097760 21687
2024-08-07 10-Q 10-Q 0001628280-24-035400 001-33277 241181750 34 5295211 1 1
2024-08-07 8-K 8-K 2.02,9.01 0001193125-24-195400 001-33277 241181392 34 234995 1 1
2024-06-27 4 4 0000950170-24-078756 9881
2024-06-27 4 4 0000950170-24-078754 7050
2024-06-27 4 4 0000950170-24-078750 7070
2024-06-27 4 4 0000950170-24-078749 7027
2024-06-27 4 4 0000950170-24-078748 8217
2024-06-27 4 4 0000950170-24-078565 26883
2024-06-27 8-K 8-K 5.02,5.07,9.01 0001193125-24-170634 001-33277 241079645 34 312328 1 1
2024-06-18 4 4 0000950170-24-075221 8595
2024-06-14 4 4 0000950170-24-073969 8594
2024-06-14 144 xsl144X01/primary_doc.xml 0001950047-24-004784 001-33277 241045999 33 7941
2024-06-14 144 xsl144X01/primary_doc.xml 0001950047-24-004778 001-33277 241045446 33 31405
2024-06-13 4 4 0000950170-24-073290 8147
2024-06-13 144 xsl144X01/primary_doc.xml 0001950047-24-004746 001-33277 241042398 33 16968
2024-06-12 144 xsl144X01/primary_doc.xml 0001950047-24-004697 001-33277 241039152 33 5640
2024-06-11 144 xsl144X01/primary_doc.xml 0001950047-24-004645 001-33277 241036905 33 13139
2024-06-06 144 xsl144X01/primary_doc.xml 0001950047-24-004505 001-33277 241026761 33 4805
2024-05-23 4 4 0000950170-24-064271 21917
2024-05-16 4 4 0000950170-24-061321 43477
2024-05-14 144 xsl144X01/primary_doc.xml 0001950047-24-003660 001-33277 24944968 33 5164
2024-05-07 8-K 8-K 1.01,1.02,8.01,9.01 0001193125-24-133196 001-33277 24922619 34 417634 1 1
2024-05-07 424B3 424B3 0001193125-24-133188 333-279168 24922596 33 446243
2024-05-07 424B5 424B5 0001193125-24-133169 333-279168 24922441 33 469711
2024-05-07 S-3ASR S-3ASR 0001193125-24-133088 333-279168 24921788 33 1337593
2024-05-07 10-Q 10-Q 0001628280-24-020865 001-33277 24919840 34 5247012 1 1
2024-05-07 8-K 8-K 2.02,9.01 0001193125-24-132559 001-33277 24919565 34 228717 1 1
2024-04-29 ARS ARS 0001193125-24-122681 001-33277 24892247 34 1314565
2024-04-29 DEFA14A DEFA14A 0001193125-24-122662 001-33277 24892089 34 459517
2024-04-29 DEF 14A DEF 14A 0001193125-24-122657 001-33277 24892047 34 5686031 1 1
2024-04-10 4 4 0000950170-24-043503 18243
2024-04-10 4 4 0000950170-24-043502 19871
2024-04-05 4 FORM 4 SUBMISSION 0000899243-24-000266 55164
2024-04-05 4 FORM 4 SUBMISSION 0000899243-24-000265 57210
2024-04-03 4 4 0000950170-24-041528 34894
2024-04-03 4 FORM 4 SUBMISSION 0000899243-24-000245 54231
2024-04-03 4 FORM 4 SUBMISSION 0000899243-24-000243 49064
2024-04-03 144 xsl144X01/primary_doc.xml 0001950047-24-002927 001-33277 24819105 33 5089
2024-04-03 144 xsl144X01/primary_doc.xml 0001950047-24-002926 001-33277 24819100 33 5192
2024-04-02 8-K 8-K 8.01 0001193125-24-084797 001-33277 24814789 34 149040 1 1
2024-04-01 144 xsl144X01/primary_doc.xml 0001950047-24-002809 001-33277 24810004 33 5146
2024-04-01 144 xsl144X01/primary_doc.xml 0001950047-24-002779 001-33277 24809670 33 5071
2024-04-01 144 xsl144X01/primary_doc.xml 0001950047-24-002775 001-33277 24809630 33 5100
2024-03-25 SC 13D/A SC 13D/A 0001104659-24-038465 005-82674 24779564 34 108079
2024-03-25 4 4 0000950170-24-035941 14245
2024-03-21 3 3 0000950170-24-034758 18607
2024-03-20 8-K 8-K 1.01,9.01 0001193125-24-072706 001-33277 24767902 34 404291 1 1
2024-03-20 424B5 424B5 0001193125-24-072686 333-256666 24767816 33 526219
2024-03-18 424B5 424B5 0001193125-24-070139 333-256666 24759070 33 489429
2024-03-15 8-K 8-K 7.01,8.01,9.01 0001193125-24-068170 001-33277 24751798 34 7502758 1 1
2024-02-28 8-K 8-K 5.02 0001193125-24-049136 001-33277 24690149 34 162048 1 1
2024-02-28 8-K 8-K 2.02,9.01 0001193125-24-049116 001-33277 24690121 34 220229 1 1
2024-02-28 10-K 10-K 0001628280-24-007376 001-33277 24690071 34 7278525 1 1
2024-02-14 SC 13G/A madrigal13ga1-12312024.htm 0001013594-24-000205 005-82674 24639697 34 75837
2024-02-14 SC 13G/A armistice-mdgl123123a2.htm 0001172661-24-001276 005-82674 24636326 34 90989
2024-02-14 SC 13G/A MADRIGAL PHARMACEUTICALS, INC. 0000902664-24-001613 005-82674 24633039 34 62826
2024-02-13 SC 13G/A JHG PLC OWNS >5% 0001274173-24-000035 005-82674 24630558 34 10644
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021394 005-82674 24628840 34 13194
2024-01-29 SC 13G/A us5588681057_012924.txt 0001086364-24-005506 005-82674 24574900 34 13794
2024-01-25 4 4 0000950170-24-007572 9844
2024-01-25 4 4 0000950170-24-007564 11701
2024-01-25 4 4 0000950170-24-007559 9832
2024-01-25 UPLOAD filename1.pdf 0000000000-24-001012 001-33277 39860
2024-01-25 4 4 0000950170-24-007356 9817
2024-01-25 4 4 0000950170-24-007348 10380
2024-01-25 4 4 0000950170-24-007347 9858
2024-01-22 SC 13G/A Madrigal_Ph_Inc.txt 0000093751-24-000043 005-82674 24547477 34 8636
2024-01-18 4 4 0000950170-24-005304 5468
2024-01-18 4 4 0000950170-24-005297 6736
2024-01-18 4 4 0000950170-24-005296 6769
2024-01-18 4 4 0000950170-24-005294 4918
2024-01-18 4 4 0000950170-24-005289 4906
2024-01-17 CORRESP filename1.htm 0001193125-24-009389 21545
2024-01-08 8-K 8-K 8.01,9.01 0001193125-24-004269 001-33277 24519480 34 1841049 1 1
2024-01-03 UPLOAD filename1.pdf 0000000000-24-000087 001-33277 42758
2023-12-18 4 4 0000950170-23-071116 16151
2023-12-14 4 FORM 4 SUBMISSION 0001209191-23-058693 68023
2023-12-14 4 FORM 4 SUBMISSION 0001209191-23-058691 80396
2023-12-14 4 4 0000950170-23-070416 16079
2023-12-14 CORRESP filename1.htm 0001193125-23-295310 24255
2023-12-13 SC 13D/A SC 13D/A 0001193125-23-294326 005-82674 231484008 34 78715
2023-12-11 4 FORM 4 SUBMISSION 0000899243-23-020582 12257
2023-12-08 CORRESP filename1.htm 0001193125-23-291715 4768
2023-12-06 4 4 0000950170-23-068575 19180
2023-12-01 4 4 0000950170-23-067360 18492
2023-11-22 4 4 0000950170-23-065902 7306
2023-11-22 3 3 0000950170-23-065900 13108
2023-11-21 UPLOAD filename1.pdf 0000000000-23-012787 001-33277 45553
2023-11-21 4 FORM 4 SUBMISSION 0001209191-23-056364 59748
2023-11-21 4 FORM 4 SUBMISSION 0001209191-23-056363 79290
2023-11-21 SC 13D/A SC 13D/A 0001104659-23-120429 005-82674 231429240 34 224006
2023-11-15 4 FORM 4 SUBMISSION 0001209191-23-055384 25425
2023-11-15 4 FORM 4 SUBMISSION 0001209191-23-055381 80979
2023-11-13 SC 13G madrigal13g-11132023.htm 0001013594-23-000909 005-82674 231399514 34 72626
2023-11-06 8-K 8-K 2.02,9.01 0001193125-23-270884 001-33277 231378323 34 230949 1 1
2023-11-06 10-Q 10-Q 0001193125-23-270803 001-33277 231378012 34 4338810 1 1
2023-10-10 SC 13G/A JHG PLC OWNS 15% 0001274173-23-000091 005-82674 231317159 34 10553
2023-10-05 SC 13D/A SC 13D/A 0001104659-23-107213 005-82674 231311802 34 130309
2023-10-05 4 FORM 4 SUBMISSION 0001209191-23-052200 21238
2023-10-02 8-K 8-K 1.01,9.01 0001193125-23-249192 001-33277 231300655 34 481031 1 1
2023-10-02 424B5 424B5 0001193125-23-249181 333-256666 231300604 33 419144
2023-09-28 424B5 424B5 0001193125-23-245600 333-256666 231289416 33 392382
2023-09-25 8-K 8-K 5.02 0001193125-23-241315 001-33277 231275840 34 148722 1 1
2023-09-14 8-K 8-K 5.02,9.01 0001193125-23-235340 001-33277 231255485 34 151764 1 1
2023-09-13 4 4 0000950170-23-047950 7729
2023-09-13 3 3 0000950170-23-047947 13670
2023-09-13 8-K 8-K 5.02,9.01 0001193125-23-234395 001-33277 231253046 34 416213 1 1
2023-09-13 8-K 8-K 8.01,9.01 0001193125-23-234385 001-33277 231252962 34 187016 1 1
2023-09-11 S-8 S-8 0001193125-23-232502 333-274459 231248149 33 271796
2023-09-08 SC 13G JHG PLC OWNS 10% 0001274173-23-000088 005-82674 231245742 34 10550
2023-08-08 SC 13D/A SC 13D/A 0001104659-23-088894 005-82674 231152552 34 102561
2023-08-08 424B3 424B3 0001193125-23-205672 333-256666 231149583 33 383577
2023-08-08 8-K 8-K 2.02,9.01 0001193125-23-205600 001-33277 231149408 34 242255 1 1
2023-08-08 10-Q 10-Q 0001193125-23-205535 001-33277 231149218 34 4154178 1 1
2023-07-17 8-K 8-K 8.01,9.01 0001193125-23-187698 001-33277 231090545 34 183823 1 1
2023-07-12 144 xsl144X01/primary_doc.xml 0001959173-23-002375 001-33277 231083876 33 5006
2023-06-30 8-K 8-K 8.01,9.01 0001193125-23-179440 001-33277 231059483 34 181942 1 1
2023-06-26 144 xsl144X01/primary_doc.xml 0001968582-23-000283 001-33277 231043761 33 4377
2023-06-26 144 xsl144X01/primary_doc.xml 0001968582-23-000281 001-33277 231043747 33 4502
2023-06-20 4 FORM 4 SUBMISSION 0000899243-23-016060 4900
2023-06-20 4 FORM 4 SUBMISSION 0000899243-23-016059 9686
2023-06-20 4 FORM 4 SUBMISSION 0000899243-23-016057 4940
2023-06-20 4 FORM 4 SUBMISSION 0000899243-23-016056 4920
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038346 20926
2023-06-20 3 FORM 3 SUBMISSION 0001209191-23-038212 2965
2023-06-20 3 FORM 3 SUBMISSION 0001209191-23-038211 24455
2023-06-20 SC 13D SC 13D 0001104659-23-072412 005-82674 231022855 34 123688
2023-06-20 8-K 8-K 5.02 0001193125-23-169190 001-33277 231022817 34 154031 1 1
2023-06-20 8-K 8-K 5.03,5.07,9.01 0001193125-23-169187 001-33277 231022804 34 177971 1 1
2023-05-09 424B5 424B5 0001193125-23-138984 333-256666 23900213 33 346206
2023-05-09 8-K 8-K 1.01,9.01 0001193125-23-138953 001-33277 23900091 34 197559 1 1
2023-05-09 8-K 8-K 2.02,9.01 0001193125-23-138931 001-33277 23900056 34 225402 1 1
2023-05-09 10-Q 10-Q 0001193125-23-138863 001-33277 23899859 34 3529818 1 1
2023-05-01 DEFA14A DEFA14A 0001193125-23-128971 001-33277 23870580 34 323508
2023-05-01 DEF 14A DEF 14A 0001193125-23-128960 001-33277 23870541 34 5007494 1 1
2023-04-21 PRE 14A PRE 14A 0001193125-23-110261 001-33277 23835899 34 3964380 1 1
2023-03-03 10-K/A 10-K/A 0001193125-23-060052 001-33277 23704242 34 5049897 1 1
2023-03-02 4 FORM 4 SUBMISSION 0000899243-23-006751 21841
2023-02-23 8-K 8-K 2.02,9.01 0001193125-23-045671 001-33277 23656006 34 235901 1 1
2023-02-23 10-K 10-K 0001193125-23-045575 001-33277 23655833 34 6469839 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021480 005-82674 23628434 34 137330
2023-02-14 SC 13G/A armistice-mdgl123122a1.htm 0001172661-23-001131 005-82674 23626101 34 90922
2023-02-14 SC 13G/A MADRIGAL PHARMACEUTICALS, INC. 0000902664-23-001684 005-82674 23623519 34 59755
2023-02-14 SC 13G/A deeptrack-mdgl123122a1.htm 0001172661-23-000841 005-82674 23623003 34 103187
2023-02-09 8-K 8-K 1.01,2.03,3.02,9.01 0001193125-23-030281 001-33277 23607150 34 745773 1 1
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016407 005-82674 23603675 34 13113
2023-02-06 SC 13G/A SEC SCHEDULE 13G 0000846087-23-000256 005-82674 23590323 34 33017
2023-02-02 SC 13G Madrigal_Pharmaceuticals_Inc.txt 0000093751-23-000091 005-82674 23579722 34 10491
2023-02-01 SC 13G/A us5588681057_020123.txt 0001306550-23-006421 005-82674 23577478 34 13531
2023-01-19 4 FORM 4 SUBMISSION 0000899243-23-002219 29547
2023-01-18 4 FORM 4 SUBMISSION 0000899243-23-002099 5005
2023-01-18 4 FORM 4 SUBMISSION 0000899243-23-002098 5072
2023-01-18 4 FORM 4 SUBMISSION 0000899243-23-002097 5646
2023-01-18 4 FORM 4 SUBMISSION 0000899243-23-002096 5058
2023-01-18 4 FORM 4 SUBMISSION 0000899243-23-002095 6828
2023-01-18 4 FORM 4 SUBMISSION 0000899243-23-002094 6798
2023-01-10 8-K 8-K 8.01 0001193125-23-005674 001-33277 23521777 34 169093 1 1
2023-01-06 4 FORM 4 SUBMISSION 0000899243-23-001137 26638
2022-12-28 4 FORM 4 SUBMISSION 0000899243-22-039464 33356
2022-12-28 4 FORM 4 SUBMISSION 0000899243-22-039463 40358
2022-12-23 424B5 424B5 0001193125-22-311541 333-256666 221483364 33 407478
2022-12-23 8-K 8-K 1.01,5.03,7.01,8.01,9.01 0001193125-22-311537 001-33277 221483346 34 573248 1 1
2022-12-19 8-K 8-K 7.01,8.01 0001193125-22-307935 001-33277 221469700 34 173862 1 1
2022-11-03 10-Q 10-Q 0001193125-22-276468 001-33277 221356437 34 3785607 1 1
2022-11-03 8-K 8-K 2.02,9.01 0001193125-22-276424 001-33277 221356333 34 231500 1 1
2022-08-12 4 FORM 4 SUBMISSION 0000899243-22-028491 5607
2022-08-04 8-K 8-K 2.02,9.01 0001193125-22-211760 001-33277 221134511 34 222843 1 1
2022-08-04 10-Q 10-Q 0001193125-22-211757 001-33277 221134508 34 4132637 1 1
2022-06-21 4 FORM 4 SUBMISSION 0000899243-22-023234 5530
2022-06-21 4 FORM 4 SUBMISSION 0000899243-22-023233 5499
2022-06-21 4 FORM 4 SUBMISSION 0000899243-22-023232 5513
2022-06-21 4 FORM 4 SUBMISSION 0000899243-22-023231 5518

Latest XBRL company facts

One latest value per concept from companyfacts (311 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 23.23M 2026-10-29 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
dei EntityPublicFloat Entity Public Float USD 5.60B 2025-06-30 2025 FY 10-K 2026-02-19 0001628280-26-009514
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt pure 958.40M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001308179-26-000352
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 16.56M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001308179-26-000352
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 6.55M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001308179-26-000352
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 125 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001308179-26-000352
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 524 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001308179-26-000352
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 61.37M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 227.38M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 391.86M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 9.21M 2025-09-30 2025 Q3 10-Q 2025-11-04 0001628280-25-048559
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 21.06M 2016-03-31 2016 Q1 10-Q 2016-05-10 0001104659-16-119512
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.73M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 2.82B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 47.59M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001047469-19-000725
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 7.93M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-31 0001047469-17-002260
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 40.35M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 860,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap AdvertisingExpense Advertising Expense USD 145.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 108.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap Assets Assets USD 1.43B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap AssetsCurrent Assets, Current USD 1.39B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1.42M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 12,485 2016-09-30 2016 Q3 10-Q/A 2017-03-31 0001104659-17-020706
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 144.70M 2018-03-31 2018 Q1 10-Q 2018-05-08 0001104659-18-031046
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 446.32M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGain Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) USD 6,000 2013-09-30 2013 Q3 10-Q 2013-11-04 0001104659-13-080239
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLosses1 Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) USD 3,000 2013-06-30 2013 Q2 10-Q 2013-08-01 0001104659-13-058569
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 1.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 43,000 2015-12-31 2015 FY 10-K 2016-03-15 0001047469-16-011140
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 22,000 2016-06-30 2016 Q2 10-Q 2016-07-20 0001104659-16-133512
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 126,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-15 0001047469-16-011140
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 43,000 2014-12-31 2015 FY 10-K 2016-03-15 0001047469-16-011140
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 44,000 2015-12-31 2015 FY 10-K 2016-03-15 0001047469-16-011140
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 44,000 2015-12-31 2015 FY 10-K 2016-03-15 0001047469-16-011140
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 44,000 2013-12-31 2013 FY 10-K 2014-03-11 0001047469-14-002088
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 44,000 2014-12-31 2014 FY 10-K 2015-03-12 0001047469-15-002022
us-gaap CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments Capital Leases, Future Minimum Payments, Interest Included in Payments USD 1,000 2015-12-31 2015 FY 10-K 2016-03-15 0001047469-16-011140
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 514.64M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 515.45M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 129.48M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001047469-18-001557
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 1.11B 2025-09-30 2025 Q3 10-Q 2025-11-04 0001628280-25-048559
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 515.45M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -269.49M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0001193125-23-270803
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 311.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 14,899 2022-05-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 23.22M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 23.22M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -99.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 4.51M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001628280-25-021356
us-gaap CostsAndExpenses Costs and Expenses USD 678.01M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-26 0001628280-25-007980
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 600,000 2022-05-09 2023 Q3 10-Q 2023-11-06 0001193125-23-270803
us-gaap DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 Debt Conversion, Converted Instrument, Warrants or Options Issued shares 14,899 2022-05-01 2023 Q3 10-Q 2023-11-06 0001193125-23-270803
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 468.91M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 115.00M 2023-09-30 2023 Q3 10-Q 2023-11-06 0001193125-23-270803
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.11 2023-09-30 2023 Q3 10-Q 2023-11-06 0001193125-23-270803
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 8.72M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap DecreaseInRestrictedCash Decrease in Restricted Cash USD 83,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001047469-19-000725
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 362,000 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 4.57M 2010-12-31 2011 FY 10-K 2012-02-22 0001047469-12-001243
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 2.16M 2010-12-31 2011 FY 10-K 2012-02-22 0001047469-12-001243
us-gaap DeferredTaxAssetsCharitableContributionCarryforwards Deferred Tax Assets, Charitable Contribution Carryforwards USD 37,000 2024-12-31 2024 FY 10-K 2025-02-26 0001628280-25-007980
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 40.78M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 591.41M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 362,000 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 214.43M 2024-12-31 2024 FY 10-K 2025-02-26 0001628280-25-007980
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.19M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 69.03M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 7.88M 2015-12-31 2015 FY 10-K 2016-03-15 0001047469-16-011140
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 21.94M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 14.96M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap DeferredTaxAssetsUnrealizedLossesOnTradingSecurities Deferred Tax Assets, Unrealized Losses on Trading Securities USD 0 2024-12-31 2024 FY 10-K 2025-02-26 0001628280-25-007980
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 591.05M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 245,000 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities Deferred Tax Liabilities, Unrealized Gains on Trading Securities USD 117,000 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 314,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-15 0001047469-16-011140
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.06 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-15 0001047469-16-011140
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 7,332 2015-12-31 2016 FY 10-K 2017-03-31 0001047469-17-002260
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.32 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -3.36 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0001193125-22-144674
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.32 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.042 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.041 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap EffectiveIncomeTaxRateReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent pure -0.153 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -370,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 62.08M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 334.20M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 7.09M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 91,000 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-07-20 0001104659-16-133512
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 108.15M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001628280-24-007376
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-15 0001047469-16-011140
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -158.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -129.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 125.69M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 9.26M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-26 0001193125-20-049021
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 5.10M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-15 0001047469-16-011140
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -60.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 835,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD -9.95M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-26 0001628280-25-007980
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 2.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD -3.40M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-26 0001628280-25-007980
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 12.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 11.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 17.68M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap IncomeTaxReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount USD 44.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap IncreaseDecreaseDueFromOtherRelatedParties Increase (Decrease) Due from Other Related Parties USD -7,332 2016-01-01 2016-09-30 2016 Q3 10-Q/A 2017-03-31 0001104659-17-020706
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 11.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 92.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap IncreaseDecreaseInAccountsReceivableRelatedParties Increase (Decrease) in Accounts Receivable, Related Parties USD -7,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001047469-19-000725
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 132.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -6.73M 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-11 0001047469-14-002088
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 58.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -839,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD -3.53M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-07-20 0001104659-16-133512
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -27,000 2015-01-01 2015-06-30 2016 Q2 10-Q 2016-07-20 0001104659-16-133512
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 41.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -282,158 2016-01-01 2016-09-30 2016 Q3 10-Q/A 2017-03-31 0001104659-17-020706
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD -116,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-11 0001047469-14-002088
us-gaap IncreaseDecreaseInRestrictedCashForOperatingActivities Increase (Decrease) in Restricted Cash for Operating Activities USD -151,000 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-22 0001047469-12-001243
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 315,070 2016-09-30 2016 Q3 10-Q/A 2017-03-31 0001104659-17-020706
us-gaap InterestExpense Interest Expense USD 3.30M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001628280-25-021356
us-gaap InterestExpenseDebtExcludingAmortization Interest Expense, Debt, Excluding Amortization USD 135.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 23.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001047469-19-000725
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 6.07M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001628280-25-021356
us-gaap InterestIncomeOperating Interest Income, Operating USD 1.08M 2022-10-01 2022-12-31 2022 FY 10-K/A 2023-03-03 0001193125-23-060052
us-gaap InterestIncomeOther Interest Income, Other USD 10.63M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0001193125-23-270803
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 923,000 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-07-20 0001104659-16-133512
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 118.91M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 9.33M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap InventoryNet Inventory, Net USD 122.59M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 113.26M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap InventoryWriteDown Inventory Write-down USD 11.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 23.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 10.28M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 555,000 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.24M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.18M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.14M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.10M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.06M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2.53M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap Liabilities Liabilities USD 807.45M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.43B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap LiabilitiesCurrent Liabilities, Current USD 454.24M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 353.20M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap LoansPayableCurrent Loans Payable, Current USD 114.73M 2023-09-30 2023 Q3 10-Q 2023-11-06 0001193125-23-270803
us-gaap LongTermDebt Long-term Debt USD 341.27M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 31.32M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 366.21M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 366.99M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 31.32M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 31.40M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 7.89M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 341.27M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD -10.93M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-11 0001104659-17-031927
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 15.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 3.40M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-11 0001104659-17-031927
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 320.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -10.56M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-11 0001104659-17-031927
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -23.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -3.77M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-11 0001104659-17-031927
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -96.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -6.36M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001104659-18-031046
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 48.60M 2015-12-31 2016 FY 10-K 2017-03-31 0001047469-17-002260
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 104.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap OperatingExpenses Operating Expenses USD 1.20B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -93.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 7.75M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.01M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 11.93M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 12.85M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 896,000 2020-12-31 2020 FY 10-K 2021-02-25 0001193125-21-056164
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 370,000 2020-12-31 2020 FY 10-K 2021-02-25 0001193125-21-056164
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 31,000 2019-12-31 2019 FY 10-K 2020-02-26 0001193125-20-049021
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 155,000 2020-12-31 2020 FY 10-K 2021-02-25 0001193125-21-056164
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 371,000 2020-12-31 2020 FY 10-K 2021-02-25 0001193125-21-056164
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 89,000 2019-09-30 2019 Q3 10-Q 2019-11-06 0001193125-19-285070
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001193125-21-056164
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.1 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 62.45M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 13.38M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -10,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0001193125-23-270803
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax USD -324,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -2.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -2.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap OtherIncome Other Income USD 0 2022-01-01 2022-12-31 2022 FY 10-K/A 2023-03-03 0001193125-23-060052
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 813,000 2012-09-30 2012 Q3 10-Q 2012-11-06 0001104659-12-074384
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 4.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0001628280-24-007376
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -3.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 32,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-12 0001047469-15-002022
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 122.19M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001104659-18-031046
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 441.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 359.55M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0001193125-23-270803
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 12.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 2.37M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 2.37M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 75.37M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ProceedsFromBankDebt Proceeds from Bank Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-26 0001628280-25-007980
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 5.85M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001047469-19-000725
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 38.28M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-09 0001104659-17-067118
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 25.80M 2012-07-01 2012-07-31 2012 Q3 10-Q 2012-11-06 0001104659-12-074384
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 219.59M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0001193125-23-270803
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 8.50M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001047469-19-000725
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 773.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 482,440 2016-01-01 2016-09-30 2016 Q3 10-Q/A 2017-03-31 0001104659-17-020706
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 15.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -288.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 21.43M 2016-03-31 2016 Q1 10-Q 2016-05-10 0001104659-16-119512
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 13.96M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits Property Subject to or Available for Operating Lease, Number of Units property 3 2015-12-31 2015 FY 10-K 2016-03-15 0001047469-16-011140
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap PurchaseObligation Purchase Obligation USD 305.90M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ReceivablesLongTermContractsOrPrograms Receivables, Long-term Contracts or Programs USD 116,000 2010-12-31 2011 FY 10-K 2012-02-22 0001047469-12-001243
us-gaap RelatedPartyTransactionRate Related Party Transaction, Rate pure 0.04 2015-06-29 2015-07-30 2018 FY 10-K 2019-02-27 0001047469-19-000725
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 21,000 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-07-20 0001104659-16-133512
us-gaap RepaymentsOfSecuredDebt Repayments of Secured Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 271.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap RestrictedCash Restricted Cash USD 5.00M 2025-09-30 2025 Q3 10-Q 2025-11-04 0001628280-25-048559
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 805,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap RestructuringCharges Restructuring Charges USD 1.24M 2009-01-01 2009-12-31 2011 FY 10-K 2012-02-22 0001047469-12-001243
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -2.19B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 1.11B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0001193125-23-270803
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-12 0001047469-15-002022
us-gaap RevenueRemainingPerformanceObligationPercentage Revenue, Remaining Performance Obligation, Percentage pure 0.02 2024-06-30 2024 Q2 10-Q 2024-08-07 0001628280-24-035400
us-gaap Revenues Revenues USD 137.25M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0001628280-25-021356
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 8.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 85.90M 2024-04-01 2024-04-30 2024 Q3 10-Q 2024-10-31 0001628280-24-044445
us-gaap SecuredDebt Secured Debt USD 6.91M 2015-09-30 2015 Q3 10-Q 2015-11-05 0001104659-15-076292
us-gaap SecuredDebtCurrent Secured Debt, Current USD 10,000 2016-06-30 2016 Q2 10-Q 2016-07-20 0001104659-16-133512
us-gaap SecuredLongTermDebt Secured Long-term Debt, Noncurrent USD 4.61M 2014-12-31 2015 FY 10-K 2016-03-15 0001047469-16-011140
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 823.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 108.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 52,063 2018-09-30 2018 Q3 10-Q 2018-11-06 0001104659-18-066115
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 9.45 2018-09-30 2018 Q3 10-Q 2018-11-06 0001104659-18-066115
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 52,064 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-06 0001104659-18-066115
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 9.45 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-06 0001104659-18-066115
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 8.07M 2015-12-31 2015 FY 10-K 2016-03-15 0001047469-16-011140
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 336.30M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 677,086 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 135.63 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 14,009 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 122,447 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 418.49M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 936,458 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 200.4 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 102.08 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 301.31 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 451.31 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap SharePrice Share Price USD/shares 9.02 2012-12-31 2012 FY 10-K 2013-03-14 0001047469-13-002698
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 138,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001193125-19-285070
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 626.94M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 36.44M 2011-06-30 2011 Q2 10-Q 2011-08-04 0001104659-11-043341
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 39,607 2020-01-01 2020-12-31 2022 FY 10-K/A 2023-03-03 0001193125-23-060052
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 151,841 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 38.24M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001047469-19-000725
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 750,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001047469-19-000725
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 9.96M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures Stock Issued During Period, Value, Restricted Stock Award, Forfeitures USD 6 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-31 0001047469-17-002260
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 21 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-31 0001047469-17-002260
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 8,000 2021-07-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001193125-21-319159
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 32,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-12 0001047469-15-002022
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 81.60M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 12.06M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 12.10M 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 3.16M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 8.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount Unrecorded Unconditional Purchase Obligation USD 9.90M 2026-06-30 2026 Q2 10-Q 2026-07-30 0001628280-26-050845
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 82.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap VariableLeaseCost Variable Lease, Cost USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001193125-19-285070
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 900,000 2023-09-30 2025 FY 10-K 2026-02-19 0001628280-26-009514
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 29.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 17.10M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0001193125-22-144674
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 29.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 29.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001628280-26-069145

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →